Existing molecular machine learning force fields (MLFFs) generally focus on the learning of atoms, molecules, and simple quantum chemical properties (such as energy and force), but ignore the importance of electron density (ED) ρ(r) in accurately understanding molecular force fields (MFFs). ED describes the probability of finding electrons at specific locations around atoms or molecules, which uniquely determines all ground state properties (such as energy, molecular structure, etc.) of interactive multi-particle systems according to the HohenbergKohn theorem. However, the calculation of ED relies on the time-consuming first-principles density functional theory (DFT), which leads to the lack of largescale ED data and limits its application in MLFFs. In this paper, we introduce EDBench, a large-scale, high-quality dataset of ED designed to advance learningbased research at the electronic scale. Built upon the PCQM4Mv2, EDBench provides accurate ED data, covering 3.3 million molecules. To comprehensively evaluate the ability of models to understand and utilize electronic information, we design a suite of ED-centric benchmark tasks spanning prediction, retrieval, and generation. Our evaluation of several state-of-the-art methods demonstrates that learning from EDBench is not only feasible but also achieves high accuracy. Moreover, we show that learning-based methods can efficiently calculate ED with comparable precision while significantly reducing the computational cost relative to traditional DFT calculations. All data and benchmarks from EDBench will be freely available, laying a robust foundation for ED-driven drug discovery and materials science.

The interpretation of genomic sequences is crucial for understanding biological processes. To handle the growing volume of DNA sequence data, Genomic Foundation Models (GFMs) have been developed by adapting architectures and training paradigms from Large Language Models (LLMs). Despite their remarkable performance in DNA sequence classification tasks, there remains a lack of systematic understanding regarding the pre-training and task-adaptation processes of GFMs. Moreover, existing GFMs cannot achieve state-of-the-art performance on both short and long-context tasks and lack multimodal abilities. By revisiting pre-training architectures and post-training techniques, we propose OMNI-DNA, a family of models spanning 20M to 1.1B parameters that supports sequence understanding, long-context genomic reasoning, and natural-language annotation. Omni-DNA establishes new state-of-the-art results on 18 of 26 evaluations drawn from Nucleotide Transformer and Genomic Benchmarks. When jointly finetuning on biologically related tasks, Omni-DNA consistently outperforms existing models and demonstrates multi-tasking abilities. Furthermore, we introduce SEQPACK, an adaptive compression mechanism that enables efficient long-context modeling by summarizing historical tokens through position-aware learnable sampling. This allows transformer-based models to process ultra-long genomic sequences with minimal memory and computational overhead.

Protein language models (PLMs) are often assumed to capture evolutionary information by training on large protein sequence datasets. Yet it remains unclear whether PLMs can reason about evolution--that is, infer evolutionary relationships between sequences. We test this capability by evaluating whether standard PLM usage, frozen or fine-tuned embeddings with distance-based comparison, supports evolutionary reasoning. Existing PLMs consistently fail to recover phylogenetic structure, despite strong performance on sequence-level tasks such as masked-token and contact prediction. We present PHYLA, a hybrid state-space and transformer model that jointly processes multiple sequences and is trained using a tree-based objective across 3,000 phylogenies spanning diverse protein families.

Deep learning techniques have driven significant progress in various analytical tasks within 3D genomics in computational biology. However, a holistic understanding of 3D genomics knowledge remains underexplored. Here, we propose MIX-HIC, the first multimodal foundation model of 3D genome that integrates both Hi-C contact maps and epigenomic tracks, which obtains unified and comprehensive semantics.

Transformers have revolutionized nucleotide sequence analysis, yet capturing long-range dependencies remains challenging. Recent studies show that autoregressive transformers often exhibit Markovian behavior by relying on fixed-length context windows for next-token prediction. However, standard self-attention mechanisms are computationally inefficient for long sequences due to their quadratic complexity and do not explicitly enforce global transition consistency. We introduce CARMANIA (Context-Aware Regularization with Markovian Integration for Attention-Based Nucleotide Analysis), a self-supervised pretraining framework that augments next-token (NT) prediction with a transition-matrix (TM) loss. The TM loss aligns predicted token transitions with empirically derived ngram statistics from each input sequence, encouraging the model to capture higherorder dependencies beyond local context.

Deep learning-based computational methods have achieved promising results in predicting protein-protein interactions (PPIs). However, existing benchmarks predominantly focus on isolated pairwise evaluations, overlooking a model's capability to reconstruct biologically meaningful PPI networks, which is crucial for biology research. To address this gap, we introduce PRING, the first comprehensive benchmark that evaluates PRotein-protein INteraction prediction from a Graph-level perspective. PRINGcurates a high-quality, multi-species PPI network dataset comprising 21,484 proteins and 186,818 interactions, with well-designed strategies to address both data redundancy and leakage. Building on this golden-standard dataset, we establish two complementary evaluation paradigms: (1) topologyoriented tasks, which assess intra and cross-species PPI network construction, and (2) function-oriented tasks, including protein complex pathway prediction, GO module analysis, and essential protein justification. These evaluations not only reflect the model's capability to understand the network topology but also facilitate protein function annotation, biological module detection, and even disease mechanism analysis. Extensive experiments on four representative model categories, consisting of sequence similarity-based, naive sequence-based, protein language model-based, and structure-based approaches, demonstrate that current PPI models have potential limitations in recovering both structural and functional properties of PPI networks, highlighting the gap in supporting real-world biological applications. We believe PRINGprovides a reliable platform to guide the development of more effective PPI prediction models for the community.

Predicting protein function from sequence is a central challenge in computational biology. While existing methods rely heavily on structured ontologies or similaritybased techniques, they often lack the flexibility to express structure-free functional descriptions and novel biological functions. In this work, we introduce Prot2TextV2, a novel multimodal sequence-to-text model that generates free-form natural language descriptions of protein function directly from amino acid sequences. Our method combines a protein language model as a sequence encoder (ESM-3B) and a decoder-only language model (LLaMA-3.1-8B-Instruct)

The interpretation of genomic sequences is crucial for understanding biological processes. To handle the growing volume of DNA sequence data, Genomic Foundation Models (GFMs) have been developed by adapting architectures and training paradigms from Large Language Models (LLMs). Despite their remarkable performance in DNA sequence classification tasks, there remains a lack of systematic understanding regarding the training and task-adaptation processes of GFMs. Moreover, existing GFMs cannot achieve state-of-the-art performance on both short and long-context tasks and lacks multimodal abilities.

China races to build record biobank to rival U.S. drugs research Biobanks store masses of biomedical data such as clinical records, genome sequences and other long-term health metrics that research and drug development depend on. As a fledgling researcher in U.S., Zhang Li was struck by the efficiency of extracting human tissue in the morning and mining it for data the same afternoon. Such a streamlined process had been missing from his years of training as a bio data scientist in China. Inspired, he returned home to Beijing to join the Chinese Institute for Brain Research and launch a national database that will collect blood and DNA samples from 33,000 children to help identify patterns of brain disease and their risk factors. "Biomedical data is extremely valuable and is fundamental for us to find solutions to diseases and to delay aging," said Zhang, surrounded by robotic arms carefully organizing blood samples.